Table:
Alfentanil group (n=129)	Fentanyl group (n=131)	P value
Cardiopulmonary complications	14 (10.9)	14 (10.7)	0.966
Systolic hypotension (<90mmHg)	12 (9.3)	11 (8.4)	0.797
MAP decreased >25%	4 (3.1)	2 (1.5)	0.445
Use of vasopressors	1 (0.8)	2 (1.5)	0.445
Bradycardia (<50 beats/min)	0	0	0.445
Hypoxemia (SpO2 < 90%)	4 (3.1)	3 (2.3)	0.721
Chin lift	4 (3.1)	1 (0.8)	0.212

Interpret the figure as Markdown format.

|  | Alfentanil group (n=129) | Fentanyl group (n=131) | P value | 
 | --- | --- | --- | --- | 
 | Cardiopulmonary complications | 14 (10.9) | 14 (10.7) | 0.966 | 
 | Systolic hypotension (<90mmHg) | 12 (9.3) | 11 (8.4) | 0.797 | 
 | MAP decreased >25% | 4 (3.1) | 2 (1.5) | 0.445 | 
 | Use of vasopressors | 1 (0.8) | 2 (1.5) | 0.445 | 
 | Bradycardia (<50 beats/min) | 0 | 0 | 0.445 | 
 | Hypoxemia (SpO2 < 90%) | 4 (3.1) | 3 (2.3) | 0.721 | 
 | Chin lift | 4 (3.1) | 1 (0.8) | 0.212 |